Susceptibility data for antimicrobials tested against H. influenzae isolates (n = 195) using CLSI disc diffusion
| . | . | Susceptible . | Intermediate . | Resistant . | |||
|---|---|---|---|---|---|---|---|
| Antimicrobial . | . | n . | (%) . | n . | (%) . | n . | (%) . |
| Chloramphenicol | all | 8 | (4.1) | 35 | (17.9) | 152 | (77.9) |
| β-lactamase neg | 6 | (5.2) | 29 | (25.0) | 81 | (69.8) | |
| β-lactamase pos | 2 | (2.5) | 6 | (7.6) | 71 | (89.9) | |
| Tetracycline | all | 3 | (1.5) | 12 | (6.2) | 180 | (92.3) |
| β-lactamase neg | 2 | (1.7) | 11 | (9.5) | 103 | (88.8) | |
| β-lactamase pos | 1 | (1.3) | 1 | (1.3) | 77 | (97.5) | |
| Trimethoprim/sulfamethoxazole | all | 31 | (15.9) | 4 | (2.1) | 160 | (82.1) |
| β-lactamase neg | 27 | (23.3) | 2 | (1.7) | 87 | (75.0) | |
| β-lactamase pos | 4 | (5.1) | 2 | (2.5) | 73 | (92.4) | |
| . | . | Susceptible . | Intermediate . | Resistant . | |||
|---|---|---|---|---|---|---|---|
| Antimicrobial . | . | n . | (%) . | n . | (%) . | n . | (%) . |
| Chloramphenicol | all | 8 | (4.1) | 35 | (17.9) | 152 | (77.9) |
| β-lactamase neg | 6 | (5.2) | 29 | (25.0) | 81 | (69.8) | |
| β-lactamase pos | 2 | (2.5) | 6 | (7.6) | 71 | (89.9) | |
| Tetracycline | all | 3 | (1.5) | 12 | (6.2) | 180 | (92.3) |
| β-lactamase neg | 2 | (1.7) | 11 | (9.5) | 103 | (88.8) | |
| β-lactamase pos | 1 | (1.3) | 1 | (1.3) | 77 | (97.5) | |
| Trimethoprim/sulfamethoxazole | all | 31 | (15.9) | 4 | (2.1) | 160 | (82.1) |
| β-lactamase neg | 27 | (23.3) | 2 | (1.7) | 87 | (75.0) | |
| β-lactamase pos | 4 | (5.1) | 2 | (2.5) | 73 | (92.4) | |
pos, positive; neg, negative.
Susceptibility data for antimicrobials tested against H. influenzae isolates (n = 195) using CLSI disc diffusion
| . | . | Susceptible . | Intermediate . | Resistant . | |||
|---|---|---|---|---|---|---|---|
| Antimicrobial . | . | n . | (%) . | n . | (%) . | n . | (%) . |
| Chloramphenicol | all | 8 | (4.1) | 35 | (17.9) | 152 | (77.9) |
| β-lactamase neg | 6 | (5.2) | 29 | (25.0) | 81 | (69.8) | |
| β-lactamase pos | 2 | (2.5) | 6 | (7.6) | 71 | (89.9) | |
| Tetracycline | all | 3 | (1.5) | 12 | (6.2) | 180 | (92.3) |
| β-lactamase neg | 2 | (1.7) | 11 | (9.5) | 103 | (88.8) | |
| β-lactamase pos | 1 | (1.3) | 1 | (1.3) | 77 | (97.5) | |
| Trimethoprim/sulfamethoxazole | all | 31 | (15.9) | 4 | (2.1) | 160 | (82.1) |
| β-lactamase neg | 27 | (23.3) | 2 | (1.7) | 87 | (75.0) | |
| β-lactamase pos | 4 | (5.1) | 2 | (2.5) | 73 | (92.4) | |
| . | . | Susceptible . | Intermediate . | Resistant . | |||
|---|---|---|---|---|---|---|---|
| Antimicrobial . | . | n . | (%) . | n . | (%) . | n . | (%) . |
| Chloramphenicol | all | 8 | (4.1) | 35 | (17.9) | 152 | (77.9) |
| β-lactamase neg | 6 | (5.2) | 29 | (25.0) | 81 | (69.8) | |
| β-lactamase pos | 2 | (2.5) | 6 | (7.6) | 71 | (89.9) | |
| Tetracycline | all | 3 | (1.5) | 12 | (6.2) | 180 | (92.3) |
| β-lactamase neg | 2 | (1.7) | 11 | (9.5) | 103 | (88.8) | |
| β-lactamase pos | 1 | (1.3) | 1 | (1.3) | 77 | (97.5) | |
| Trimethoprim/sulfamethoxazole | all | 31 | (15.9) | 4 | (2.1) | 160 | (82.1) |
| β-lactamase neg | 27 | (23.3) | 2 | (1.7) | 87 | (75.0) | |
| β-lactamase pos | 4 | (5.1) | 2 | (2.5) | 73 | (92.4) | |
pos, positive; neg, negative.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
